Brief: Brainsway Receives FDA Clearance For Three-Minute Theta Burst Treatment Protocol For Major Depressive Disorder
26/04/2021 12:37
April 26 (Reuters) - Brainsway Ltd BWAY.TA :
* BRAINSWAY RECEIVES FDA CLEARANCE FOR THREE-MINUTE THETA
BURST
TREATMENT PROTOCOL FOR MAJOR DEPRESSIVE DISORDER
* BRAINSWAY LTD - BRAINSWAY THETA BURST PROTOCOL WILL BE
IMMEDIATELY AVAILABLE ON ALL BRAINSWAY SYSTEMS ALREADY
INSTALLED.
Source text for Eikon: ID:nGNXZJp10
Further company coverage: BWAY.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Brainsway
See all newsBrief: Brainsway Presents Positive Data From Largest Real-World Study Of Deep Tms™ In Patients With Comorbid Ptsd And Major Depressive Disorder
Brief: Brainsway Announces Minority-Stake Investment In Hopemark Health
Brief: Brainsway Announces New Minority-Stake Investment In Canadian Provider, Brainstim Health Inc.
Brief: Brainsway Announces Change In ADS-To-Ordinary Share Ratio
Brief: BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)